Sign up online today & collaborate
or click here to find out more
Cardiff, UK – Celixir, a leading British biotechnology company delivering breakthrough regenerative medicines, has today rebranded from Cell Therapy. The change reflects the company’s continued commitment to discovering, developing and delivering life-altering regenerative medicines, and transforming patient care.
“The name Celixir combines ‘Cell’ with the Latin root word elixir to convey our vision to develop curative regenerative medicines”, said Ajan Reginald, Chief Executive Officer of Celixir. “Adopting the Celixir name signals the company’s evolution with an expanded portfolio of medicines, international partnerships and robust financial position. It’s a fitting way to mark our 7th anniversary”.
To coincide with the rebrand, Celixir has unveiled a new logo and website http://www.celixir.com. The new site offers the latest information about the company’s platform technology, product portfolio, clinical evidence and stellar leadership, in an easy-to-use format.
The rebrand is effective immediately and will be implemented across all of the company’s platforms and all future communications.